Stay updated on Ferumoxytol MRI in Glioblastoma Response Clinical Trial
Sign up to get notified when there's something new on the Ferumoxytol MRI in Glioblastoma Response Clinical Trial page.

Latest updates to the Ferumoxytol MRI in Glioblastoma Response Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoNo Change Detected
- Check20 days agoChange DetectedMajor change: page now advertises a government operating status notice and updates the release version to v3.2.0; the previous v3.1.0 version tag was removed.SummaryDifference3%

- Check27 days agoChange DetectedUpdated the page revision from v3.0.2 to v3.1.0, indicating a new software release or document update. No changes to core content, pricing, or stock are evident.SummaryDifference0.1%

- Check42 days agoChange DetectedThe page now reflects termination and a PI transition, posted results, and a protocol update (v3.0.2) with a smaller sample size (52) and new survival/safety endpoints; older immunology endpoints were removed.SummaryDifference18%

- Check49 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. There are no significant changes to core content or important information.SummaryDifference0.2%

- Check56 days agoChange DetectedThe web page has undergone significant changes, including the addition of a facility name and location, as well as new content related to various chemical compounds and analytical techniques. Notably, the previous version's references to specific medical topics and compounds have been removed.SummaryDifference2%

- Check70 days agoChange DetectedThe web page has been updated from version 2.16.11 to version 2.16.12.SummaryDifference0.1%

Stay in the know with updates to Ferumoxytol MRI in Glioblastoma Response Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Ferumoxytol MRI in Glioblastoma Response Clinical Trial page.